Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Reversing bone loss by directing mesenchymal stem cells to bone.

Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE.

Stem Cells. 2013 Sep;31(9):2003-14. doi: 10.1002/stem.1461. Erratum in: Stem Cells. 2014 Feb;32(2):601.

PMID:
23818248
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass.

Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE.

Nat Med. 2012 Feb 5;18(3):456-62. doi: 10.1038/nm.2665.

PMID:
22306732
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice.

An JH, Park H, Song JA, Ki KH, Yang JY, Choi HJ, Cho SW, Kim SW, Kim SY, Yoo JJ, Baek WY, Kim JE, Choi SJ, Oh W, Shin CS.

Tissue Eng Part A. 2013 Mar;19(5-6):685-96. doi: 10.1089/ten.TEA.2012.0047. Epub 2013 Jan 5.

PMID:
23215868
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.

Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T, Crane J, Frassica F, Zhang L, Rodriguez JP, Xiaofeng Jia, Shoshana Yakar, Shouhong Xuan, Argiris Efstratiadis, Mei Wan, Xu Cao.

Nat Med. 2012 Jul;18(7):1095-101. doi: 10.1038/nm.2793.

PMID:
22729283
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Targeted delivery of mesenchymal stem cells to the bone.

Yao W, Lane NE.

Bone. 2014 Aug 28. pii: S8756-3282(14)00287-7. doi: 10.1016/j.bone.2014.07.026. [Epub ahead of print]

PMID:
25173607
[PubMed - as supplied by publisher]
6.

Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.

Li X, Ling W, Khan S, Yaccoby S.

J Bone Miner Res. 2012 Aug;27(8):1635-48. doi: 10.1002/jbmr.1620.

PMID:
22460389
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.

Yu B, Zhao X, Yang C, Crane J, Xian L, Lu W, Wan M, Cao X.

J Bone Miner Res. 2012 Sep;27(9):2001-14. doi: 10.1002/jbmr.1663.

PMID:
22589223
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.

Saidak Z, Haÿ E, Marty C, Barbara A, Marie PJ.

Aging Cell. 2012 Jun;11(3):467-74. doi: 10.1111/j.1474-9726.2012.00804.x. Epub 2012 Mar 12.

PMID:
22321691
[PubMed - indexed for MEDLINE]
Free Article
9.

Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.

Xia WF, Jung JU, Shun C, Xiong S, Xiong L, Shi XM, Mei L, Xiong WC.

J Bone Miner Res. 2013 Oct;28(10):2122-35. doi: 10.1002/jbmr.1954.

PMID:
23649480
[PubMed - indexed for MEDLINE]
10.

Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.

Duque G, Rivas D.

J Bone Miner Res. 2007 Oct;22(10):1603-11.

PMID:
17605634
[PubMed - indexed for MEDLINE]
11.

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F.

BMC Cancer. 2010 Jun 17;10:298. doi: 10.1186/1471-2407-10-298.

PMID:
20565769
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting integrins to promote bone formation and repair.

Marie PJ.

Nat Rev Endocrinol. 2013 May;9(5):288-95. doi: 10.1038/nrendo.2013.4. Epub 2013 Jan 29. Review.

PMID:
23358353
[PubMed - indexed for MEDLINE]
13.

DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.

Abdallah BM, Ditzel N, Mahmood A, Isa A, Traustadottir GA, Schilling AF, Ruiz-Hidalgo MJ, Laborda J, Amling M, Kassem M.

J Bone Miner Res. 2011 Jul;26(7):1457-71. doi: 10.1002/jbmr.346.

PMID:
21308776
[PubMed - indexed for MEDLINE]
14.

Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells.

Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW, Su Y.

J Bone Miner Res. 2009 May;24(5):837-48. doi: 10.1359/jbmr.081257.

PMID:
19113920
[PubMed - indexed for MEDLINE]
15.

Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.

Guang LG, Boskey AL, Zhu W.

Int J Biochem Cell Biol. 2013 Aug;45(8):1813-20. doi: 10.1016/j.biocel.2013.05.034. Epub 2013 Jun 4.

PMID:
23742988
[PubMed - indexed for MEDLINE]
16.

Petroleum ether extract of Cissus quadrangularis (Linn.) enhances bone marrow mesenchymal stem cell proliferation and facilitates osteoblastogenesis.

Potu BK, Bhat KM, Rao MS, Nampurath GK, Chamallamudi MR, Nayak SR, Muttigi MS.

Clinics (Sao Paulo). 2009;64(10):993-8. doi: 10.1590/S1807-59322009001000010.

PMID:
19841707
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.

Gilmour PS, O'Shea PJ, Fagura M, Pilling JE, Sanganee H, Wada H, Courtney PF, Kavanagh S, Hall PA, Escott KJ.

Toxicol Appl Pharmacol. 2013 Oct 15;272(2):399-407. doi: 10.1016/j.taap.2013.07.001. Epub 2013 Jul 18.

PMID:
23872097
[PubMed - indexed for MEDLINE]
Free Article
18.

The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.

Peng S, Zhang G, Zhang BT, Guo B, He Y, Bakker AJ, Pan X, Zhen W, Hung L, Qin L, Leung WN.

Bone. 2013 Jul;55(1):230-40. doi: 10.1016/j.bone.2013.02.012. Epub 2013 Feb 26.

PMID:
23486180
[PubMed - indexed for MEDLINE]
19.

Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects.

Granero-Moltó F, Myers TJ, Weis JA, Longobardi L, Li T, Yan Y, Case N, Rubin J, Spagnoli A.

Stem Cells. 2011 Oct;29(10):1537-48. doi: 10.1002/stem.697.

PMID:
21786367
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.

Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM.

Arch Med Res. 2013 Jul;44(5):325-34. doi: 10.1016/j.arcmed.2013.05.002. Epub 2013 Jul 16.

PMID:
23867791
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk